Carl June, MD, Talks CAR T-cell Therapies at AACR Conference
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Author:
Karen Olsen, PhD
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
Anthracyclines, a widely used class of chemotherapeutics, work in several ways to kill rapidly dividing cells, including those found...
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...